NCT02952612

Brief Summary

Papillary thyroid microcarcinoma are small thyroid cancer measuring 1cm or less. Most of this tumor are not palpable and are identified either through pathologic examination or from imaging modalities, such as CT scan or thyroid sono. Active surveillance of papillary microcarcinoma is to observe thyroid papillary cancer without immediate surgical approach. The purpose of this study is to understand more about the characteristics of papillary microcarcinoma, which has been known for "the cancer slowly progression"

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 31, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 2, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

November 8, 2016

Status Verified

November 1, 2016

Enrollment Period

1 year

First QC Date

October 31, 2016

Last Update Submit

November 5, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Progression of papillary thyroid microcarcinoma

    Using thyroid sonography, check any changes in size and shape of papillary thyroid microcarcinoma

    5 years after enrollment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This observational study enrolls patients who was diagnosed as papillary thyroid microcarcinoma by FNA (Fine needle aspiration) or CNA(Core needle aspiration) and who wish to be enrolled this study.

You may qualify if:

  • \< 1 cm solitary nodule
  • Surrounded by ≥ 2 mm normal thyroid parenchyma
  • Subcapsular locations not adjacent to surrounding structures, recurrent laryngeal nerve, trachea, or carotid artery
  • No evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery
  • No extrathyroidal extension
  • Clinically N0 and Clinically M0
  • ≥ 18 years
  • Combined severe comorbidities or Inoperable condition (optional)
  • No wish to surgery and Willingness to accept active surveillance
  • No history of radiotherapy on head and neck area
  • Accepted by the Board of Thyroid Cancer Meeting

You may not qualify if:

  • ≥ 1 cm nodule and multifocal nodules regardless of size
  • Papillary thyroid carcinoma variants associated with poor prognosis (tall cell variant, columnar variant, hobnail variant) or other types of thyroid cancer)
  • Subcapsular locations adjacent to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery
  • Evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery
  • Extrathyroidal extension
  • Any of N1 or M1
  • Documented increase in size according to America Thyroid Association (ATA) guideline in a previously confirmed Papillary thyroid microcarcinoma
  • \< 18 years
  • Not willing to accept observational active surveillance approach

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul St Mary's Hospital

Seoul, Seocho-Gu, 137-701, South Korea

RECRUITING

MeSH Terms

Conditions

Thyroid Cancer, Papillary

Condition Hierarchy (Ancestors)

Adenocarcinoma, PapillaryAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsThyroid NeoplasmsEndocrine Gland NeoplasmsNeoplasms by SiteHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Officials

  • Dong-Jun Lim, MD, PhD

    Seoul St. Mary's Hospital

    STUDY CHAIR

Central Study Contacts

Kwanhoon Jo, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 31, 2016

First Posted

November 2, 2016

Study Start

October 1, 2016

Primary Completion

October 1, 2017

Study Completion

October 1, 2021

Last Updated

November 8, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will share

Locations